In many cancer types, the expression of Foxf2 is repressed by promoter hypermethylation or by oncogenic microRNAs (miRNAs), such as miR-301, which promotes breast cancer cell proliferation, invasion, and tumor growth [40, 41], indicating that Foxf2 may act as a tumor suppressor. Here, FOXF2 is linked to cancer.